Table 5 Affordability of anticancer medicines by high, middle and low-income class patients in Punjab, Pakistan
Sr. No. | Medicine and Dose | OB | Overall OB | LPG | Overall LPG | Overall both (OB + LPG) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
High | Middle | Low | High | Middle | Low | |||||
1 | Anastrozole 1 mg tab | 100 | 50.1 | 18.3 | 71.5 | 100 | 68.3 | 20.6 | 63.2 | 68.2 |
2 | Bicalutamide 50 mg tab | 100 | 28.2 | 12.4 | 48.9 | 100 | 100 | 73.8 | 93.3 | 66.4 |
3 | Bleomycin 15 mg inj | 68.3 | 18.1 | 6.5 | 27.8 | 78.8 | 46.6 | 15.4 | 46.9 | 36.0 |
4 | Capecitabine 500 mg tab | 61.9 | 25.0 | 8.1 | 35.5 | NA | NA | NA | NA | 35.5 |
5 | Carboplatin 150 mg inj | 100 | 93.1 | 32.7 | 79.3 | 100 | 100 | 77.1 | 93.6 | 85.0 |
6 | Cisplatin 50 mg inj | 100 | 100 | 60 | 91.6 | 100 | 100 | 97.5 | 99.3 | 94.4 |
7 | Cyclophosphamide 500 mg inj | 100 | 65.5 | 28.0 | 70.5 | 100 | 95.9 | 57 | 86.6 | 77.0 |
8 | Cyproterone Acetate 50 mg tab | 100 | 99.5 | 43.8 | 84.5 | NA | NA | NA | NA | 84.5 |
9 | Cytarabine 100 mg inj | 100 | 100 | 69.9 | 92.5 | 100 | 100 | 100 | 100 | 94.7 |
10 | Dacarbazine 200 mg inj | 100 | 77.8 | 53.6 | 78.3 | 100 | 100 | 67.9 | 90 | 83.4 |
11 | Dactinomycin 0.5 mg inj | 100 | 42.6 | 14.7 | 66.1 | 100 | 51.8 | 17.8 | 56.4 | 62.3 |
12 | Daunomycin 20 mg inj | 100 | 50.3 | 15.7 | 58.1 | 100 | 100 | 43.3 | 85.6 | 69.0 |
13 | Docetaxil 80 mg inj | 31.8 | 5.5 | 3.2 | 15.1 | NP | NP | NP | NP | 15.1 |
14 | Doxorubicin 50 mg inj | 100 | 62.5 | 27.8 | 68.7 | 100 | 93.5 | 39.5 | 80.3 | 73.0 |
15 | Epirubicin 50 mg inj | 75.3 | 28.6 | 9.0 | 44.2 | 96.4 | 38.1 | 19.1 | 55.3 | 48.6 |
16 | Etoposide 100 mg inj | 100 | 77.4 | 31.0 | 74.6 | 100 | 92.4 | 43.9 | 82.1 | 77.6 |
17 | Fludarabine phosphate 50 mg inj | 30.1 | 8.2 | 2.8 | 15.9 | 40.3 | 11.1 | 5.1 | 2.7 | 17.8 |
18 | Flourouracil 500 mg inj | 100 | 100 | 60.9 | 90.6 | 100 | 100 | 100 | 100 | 94.4 |
19 | Gemicitabine 1 g inj | 21.3 | 9.7 | 3.5 | 13.2 | 32.4 | 13.5 | 5.2 | 18.1 | 15.1 |
20 | Hydroxyurea 500 mg cap | 100 | 100 | 100 | 100 | NP | NP | NP | NP | 100 |
21 | Ifosfamide I gminj | 62.9 | 29.5 | 9.1 | 42.3 | 62.9 | 29.2 | 8.8 | 33.5 | 38.8 |
22 | Imatinibmesylate 400 mg tab | 7.2 | 2.4 | 0.8 | 3.6 | NA | NA | NA | NA | 3.6 |
23 | Irinotecan 100 mg inj | 6.7 | 2.2 | 1.0 | 3.8 | 11.6 | 4.4 | 2.1 | 6.5 | 4.9 |
24 | Lapatinib 250 mg tab | 8.0 | 3.0 | 1.0 | 5.1 | NA | NA | NA | NA | 5.1 |
25 | Letrozole 2.5 mg tab | 86.5 | 40.7 | 12.6 | 58.3 | 100 | 68.7 | 20.7 | 63.3 | 60.3 |
26 | Mercaptopurine 50 mg tab | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
27 | Methotrexate 10 mg tab | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
28 | Mitomycin 10 mg inj | 100 | 100 | 48.5 | 89.2 | 100 | 100 | 100 | 100 | 93.5 |
29 | Mitoxantrone 20 mg inj | 100 | 100 | 52.5 | 90.1 | NA | NA | NA | NA | 90.1 |
30 | Nilotinib 200 mg cap | 2.2 | 0.9 | 0.3 | 1.4 | NA | NA | NA | NA | 1.4 |
31 | Oxalplatin 100 mg inf | 14.5 | 5.8 | 2.0 | 8.2 | 18.0 | 6.6 | 3.5 | 10.3 | 9.1 |
32 | Paclitaxel 260 mg inf | 23.9 | 8.5 | 4.6 | 15.6 | 23.9 | 14.6 | 5.0 | 14.5 | 15.1 |
33 | Pazopanib 400 mg tab | 14.8 | 3.5 | 1.4 | 6.8 | NA | NA | NA | NA | 6.8 |
34 | Sorafenib 200 mg tab | 6.3 | 3.2 | 1.1 | 4.3 | NA | NA | NA | NA | 4.3 |
35 | Sunitinib 50 mg cap | 6.7 | 1.6 | 0.6 | 3.1 | NA | NA | NA | NA | 3.1 |
36 | Tamoxifen 20 mg tab | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
37 | Thalidomide 100 mg cap | 100 | 67.7 | 24.3 | 75.1 | NA | NA | NA | NA | 75.1 |
38 | Vinblastine 10 mg inj | 100 | 43.2 | 15.6 | 50.5 | 100 | 100 | 43.9 | 81.3 | 63.7 |
39 | Vincristine 2 mg inj | 100 | 100 | 85.2 | 96.3 | 100 | 100 | 99.4 | 99.8 | 97.6 |
40 | Vinorelbine 50 mg inj | 100 | 8.7 | 4.8 | 54.6 | 100 | 15.1 | 5.1 | 39.2 | 48.5 |
Total | 70.7 | 49.1 | 29.2 | 53.4 | 84.4 | 69.6 | 49.0 | 67.9 | 55.5 | |